VanEck Associates
STAA icon

VanEck Associates’s STAAR Surgical STAA Stock Holding History

VanEck Associates’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,478
Closed -$105K – 1427
2024
Q3 		$105K Buy
3,478
+393
+13% +$14.7K ﹤0.01% 1249
2024
Q2 		$147K Sell
3,085
-606
-16% -$26.6K ﹤0.01% 1221
2024
Q1 		$141K Buy
3,691
+253
+7% +$8.22K ﹤0.01% 1216
2023
Q4 		$107K Buy
3,438
+254
+8% +$9.13K ﹤0.01% 1230
2023
Q3 		$128K Buy
3,184
+980
+44% +$45.9K ﹤0.01% 1198
2023
Q2 		$116K Buy
2,204
+143
+7% +$8.71K ﹤0.01% 1224
2023
Q1 		$132K Buy
2,061
+105
+5% +$6.85K ﹤0.01% 1211
2022
Q4 		$95K Buy
+1,956
New +$123K ﹤0.01% 1258

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

VanEck Associates's STAA Position: Q4 2024 in Review

VanEck Associates sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 3,478 shares — an estimated $105K sold.

VanEck Associates first reported a position in STAA in Q4 2022 and held it in 8 quarters. The position peaked at $147K in Q2 2024. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

  • VanEck Associates reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
  • VanEck Associates sold 3,478 STAAR Surgical shares in Q4 2024, an estimated $105K.
  • VanEck Associates first reported a position in STAAR Surgical in Q4 2022 and held it in 8 quarters.
  • VanEck Associates's STAAR Surgical position peaked at $147K in Q2 2024.
  • 212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.